Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.

Neurology

Volumn 70, Issue 22 Pt 2, 2008, Pages 2179-2186

  LeLorier, J ^a   Duh, M S ^a   Paradis, P E ^a   Lefebvre, P ^a   Weiner, J ^a   Manjunath, R ^a   Sheehy, O ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GENERIC DRUG; LAMOTRIGINE; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PHARMACY; PRESCRIPTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS; TIME;

ADULT; ANTICONVULSANTS; COHORT STUDIES; DRUG UTILIZATION; DRUGS, GENERIC; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHARMACY; PRESCRIPTIONS, DRUG; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TRIAZINES;

MLCS; MLOWN;

EID: 45949086485     PISSN: None     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000313154.55518.25     Document Type: Article

References (0)